In his new role, Mr. Isom will lead Alcami’s commercial strategy for laboratory services. Read More >>
The $45 million investment expands domestic sterile manufacturing capacity for pharma and biotech clients.
Designed for your formulation and supply chain requirements, our tailored solutions help reduce risk and improve efficiency.
The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.
Two-day event will bring the biopharma outsourcing community together April 1-2, 2027.
A Global CRDMO - Accelerating Drug Product Development From R&D to Clinical and all the way to Commercials in Sterile and Non-Sterile dosage form.
The acquisition supports Piramal Pharma’s biologics strategy and strengthens its ADCelerate platform.
Next-gen engineered enzyme designed to make the critical step of converting RNA to cDNA faster.
Following acquisition of LOG Pharma, Perlen now offers broad portfolio of bottles for OSD and liquid applications.
New and expanded facilities will support rising demand for late-stage clinical bioanalysis.
New platform streamlines small-scale virus filtration for biopharma and gene therapy workflows.
